Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.49 +0.11 (+0.51%)
As of: Nov 16, 2026 · 9:46 AM EST

Amneal Pharmaceuticals (AMRX) EBITDA (2017 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) recorded EBITDA of $152.86 million in Q3 2026, up 24.4% from $122.86 million a year earlier but down 15.8% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) EBITDA (2017 - 2026) Analysis & Trends

On a TTM basis, Amneal Pharmaceuticals' EBITDA came in at $688.32 million as of Sep 30, 2026, up 10.3% year-over-year; for FY2025, it came in at $640.1 million, up 24.4% from FY2024.

  • Annual EBITDA has increased for three straight years, with a five-year compound annual growth rate of 13.8% (FY2020 to FY2025).
  • Across earlier years, EBITDA came in at $514.61 million in FY2024 (+15.6%), $445.32 million in FY2023 (+189.5%), $153.84 million in FY2022 (-61.1%) and $395.33 million in FY2021 (+17.9%).
  • Quarterly EBITDA has ranged from -$136.73 million in Q2 2022 to $188.85 million in Q1 2026 over the past five years.
  • On a year-over-year basis, EBITDA rose in six of the last eight quarters, with growth averaging 45.5%.
  • Peak year-over-year performance for EBITDA in the last five years was growth of 227.6% in Q1 2025, against a decline of 45.5% in Q1 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $181.63 million (Q2 2026), $188.85 million (Q1 2026) and $164.98 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,305.71 Bn 1,279.33 Bn 20.46 Bn 8.95 Bn
2 Johnson & Johnson 694.23 Bn 614.09 Bn 17.30 Bn 8.30 Bn
3 AbbVie 528.96 Bn 496.97 Bn 13.12 Bn 8.16 Bn
4 Merck 365.92 Bn 328.86 Bn 13.19 Bn 7.34 Bn
5 Novartis Ag 314.95 Bn 288.19 Bn - -
6 Astrazeneca 289.15 Bn 262.67 Bn 13.26 Bn 5.99 Bn
7 Amgen 254.11 Bn 205.76 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 211.85 Bn 186.96 Bn 6.73 Bn 4.20 Bn
9 Pfizer 165.73 Bn 113.09 Bn 12.56 Bn 7.05 Bn
10 Amneal Pharmaceuticals 7.21 Bn 6.44 Bn 334.12 Mn 152.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 152.86 Mn
Jun 30, 2026 181.63 Mn
Mar 31, 2026 188.85 Mn
Dec 31, 2025 164.98 Mn
Sep 30, 2025 122.86 Mn
Jun 30, 2025 183.66 Mn
Mar 31, 2025 169.02 Mn
Dec 31, 2024 148.74 Mn
Sep 30, 2024 157.80 Mn
Jun 30, 2024 158.49 Mn
Mar 31, 2024 51.59 Mn
Dec 31, 2023 75.79 Mn
Sep 30, 2023 142.72 Mn
Jun 30, 2023 139.66 Mn
Mar 31, 2023 94.66 Mn
Dec 31, 2022 99.19 Mn
Sep 30, 2022 76.56 Mn
Jun 30, 2022 -136.73 Mn
Mar 31, 2022 83.32 Mn
Dec 31, 2021 74.69 Mn
API Access

Amneal Pharmaceuticals EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=AMRX&period=max&api_key=YOUR_API_KEY